Monday 20 September 2021 ,
Latest News
Saudi Arabia keen to invest more in Bangladesh |
9 September, 2021 11:22:24 AM / LAST MODIFIED: 9 September, 2021 04:34:04 PM

Print

Nerve disorder listed as 'very rare' side effect of AstraZeneca vaccine

BSS/AFP, New York
Nerve disorder listed as 'very rare' side effect of AstraZeneca vaccine

The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine.

A causal relationship was "considered at least a reasonable possibility", the EMA said in an update Wednesday after a total of 833 cases of the
syndrome had been reported worldwide by July 31, from about 592 million doses of the AstraZeneca "Vaxzevria" shot administered.

"GBS should therefore be added to the product information as a side effect of Vaxzevria," the Amsterdam-based agency said.

Guillain-Barre Syndrome was a "very rare" side effect, occurring in under one in 10,000 people, it added.

The disorder is a nerve inflammation that may cause temporary paralysis and difficulty breathing.

In the United States, the very rare syndrome affects an estimated 3,000 to 6,000 people each year and most go on to recover.

The EMA recommended that a warning be added to information on the vaccine that tells people to seek medical attention if they develop weakness and paralysis in the extremities that can progress to the chest and face.

The European drug regulator had in July listed Guillain-Barre syndrome as a "very rare" side effect of the Johnson & Johnson vaccine, which uses the same adenovirus technology as the AstraZeneca jab.

The US Food and Drug Administration also warned in July of an "increased risk" of developing the neurological syndrome with Johnson & Johnson's dose.

Both regulators stressed that the vaccine's benefits outweighed the potential risks.

 

TH

 

.

Comments

Poll
Today's Question »
State minister for power Nasrul Hamid yesterday said everyone to have access to electricity by June. Do you think the feat achievable by the timeframe?
 Yes
 No
 No Comment
Yes 47.3%
No 48.7%
No Comment 4.1%
Video

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting